SUBSCRIBE
SUBSCRIBE
News   Policy

Merck KGaA Says Sees EU Statement on MS Pill in Q3

April 9, 2010 | 
1 min read
Reuters -- Germany's Merck KGaA still sees its application for European approval of multiple sclerosis pill cladribine on track, while regulatory clearance in the United States remains uncertain.
Regulatory Europe
MORE ON THIS TOPIC
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus. 3d rendering
IN PARTNERSHIP WITH VIVA BIOTECH
Cyclic peptides open new drug frontiers, if manufacturing can keep up
September 14, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
Creative background as a blue abstract extreme perspective design element representing time travel or Psychedelic and hallucinogenic consciousness trip as a 3D illustration.
Psychedelics
Psychedelic therapies ride wave of public favor into FDA hearing
September 14, 2026
 · 
3 min read
 · 
Michael Gibney
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Alarm clock with pause sign, take a break, menopause concept, hormone replacement therapy
FDA
Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
September 10, 2026
 · 
3 min read
 · 
Heather McKenzie